Investigating post-COVID-19 confidence in emergency use authorization vaccines: A hypothetical case of mpox.

<h4>Background</h4>The COVID-19 pandemic has profoundly influenced public trust in vaccines, particularly those authorized under Emergency Use Authorization (EUA). In light of the recent monkeypox (mpox) outbreak, the primary aim of this study is to uncover how experiences with the COVID...

Full description

Saved in:
Bibliographic Details
Main Authors: Li Ping Wong, Haridah Alias, Hai Yen Lee, Qinjian Zhao, Zhiwen Huang, Zhijian Hu, Yulan Lin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-05-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0013037
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839650508442173440
author Li Ping Wong
Haridah Alias
Hai Yen Lee
Qinjian Zhao
Zhiwen Huang
Zhijian Hu
Yulan Lin
author_facet Li Ping Wong
Haridah Alias
Hai Yen Lee
Qinjian Zhao
Zhiwen Huang
Zhijian Hu
Yulan Lin
author_sort Li Ping Wong
collection DOAJ
description <h4>Background</h4>The COVID-19 pandemic has profoundly influenced public trust in vaccines, particularly those authorized under Emergency Use Authorization (EUA). In light of the recent monkeypox (mpox) outbreak, the primary aim of this study is to uncover how experiences with the COVID-19 vaccination have shaped public trust in hypothetical EUA vaccines for mpox.<h4>Method</h4>A nationwide cross-sectional survey using an online questionnaire was conducted across six regions in China. Trust in future EUA vaccines, influenced by the COVID-19 vaccination experience as well as other attitudinal and behavioral factors associated with the willingness to receive an EUA-authorized mpox vaccine, was analyzed using partial least squares structural equation modelling (PLS-SEM).<h4>Results</h4>The overall willingness to receive an EUA-authorized mpox vaccine across all regions is 67.9%. The less economically developed Northeastern and Northwestern regions, with willingness rates of 84.9% and 81.8%, respectively, showed higher intention to be vaccinated than the more affluent Eastern region, which reported a willingness rate of 71.2%. There is a generally positive influence of the COVID-19 vaccination experiences on trust in future EUA vaccines, with a combined total of 61.8% (41.5% reported a somewhat increased level of trust and 20.3% reported a significantly increased level of trust). This trust emerged as the strongest determinant of vaccination willingness (β = 0.441, p < 0.001). Other factors influencing willingness include fear of the disease (β = 0.096, p < 0.001), knowledge (β = 0.064, p = 0.017), and prevention practices (β = 0.066, p = 0.005). Additionally, significant but smaller effects were noted for education (β = 0.059, p = 0.005) and urban-rural locality (β = -0.053, p = 0.012).<h4>Conclusion</h4>Findings underscore the importance of bolstering public trust in EUA vaccines, as well as addressing related attitudinal and behavioral factors, to enhance acceptance of mpox vaccines. This requires transparent communication about the rigorous approval process, continuous safety monitoring, and real-world effectiveness of EUA vaccines.
format Article
id doaj-art-8e70d2f3e9c84b45baef747e0c0cc84b
institution Matheson Library
issn 1935-2727
1935-2735
language English
publishDate 2025-05-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj-art-8e70d2f3e9c84b45baef747e0c0cc84b2025-06-27T05:32:04ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352025-05-01195e001303710.1371/journal.pntd.0013037Investigating post-COVID-19 confidence in emergency use authorization vaccines: A hypothetical case of mpox.Li Ping WongHaridah AliasHai Yen LeeQinjian ZhaoZhiwen HuangZhijian HuYulan Lin<h4>Background</h4>The COVID-19 pandemic has profoundly influenced public trust in vaccines, particularly those authorized under Emergency Use Authorization (EUA). In light of the recent monkeypox (mpox) outbreak, the primary aim of this study is to uncover how experiences with the COVID-19 vaccination have shaped public trust in hypothetical EUA vaccines for mpox.<h4>Method</h4>A nationwide cross-sectional survey using an online questionnaire was conducted across six regions in China. Trust in future EUA vaccines, influenced by the COVID-19 vaccination experience as well as other attitudinal and behavioral factors associated with the willingness to receive an EUA-authorized mpox vaccine, was analyzed using partial least squares structural equation modelling (PLS-SEM).<h4>Results</h4>The overall willingness to receive an EUA-authorized mpox vaccine across all regions is 67.9%. The less economically developed Northeastern and Northwestern regions, with willingness rates of 84.9% and 81.8%, respectively, showed higher intention to be vaccinated than the more affluent Eastern region, which reported a willingness rate of 71.2%. There is a generally positive influence of the COVID-19 vaccination experiences on trust in future EUA vaccines, with a combined total of 61.8% (41.5% reported a somewhat increased level of trust and 20.3% reported a significantly increased level of trust). This trust emerged as the strongest determinant of vaccination willingness (β = 0.441, p < 0.001). Other factors influencing willingness include fear of the disease (β = 0.096, p < 0.001), knowledge (β = 0.064, p = 0.017), and prevention practices (β = 0.066, p = 0.005). Additionally, significant but smaller effects were noted for education (β = 0.059, p = 0.005) and urban-rural locality (β = -0.053, p = 0.012).<h4>Conclusion</h4>Findings underscore the importance of bolstering public trust in EUA vaccines, as well as addressing related attitudinal and behavioral factors, to enhance acceptance of mpox vaccines. This requires transparent communication about the rigorous approval process, continuous safety monitoring, and real-world effectiveness of EUA vaccines.https://doi.org/10.1371/journal.pntd.0013037
spellingShingle Li Ping Wong
Haridah Alias
Hai Yen Lee
Qinjian Zhao
Zhiwen Huang
Zhijian Hu
Yulan Lin
Investigating post-COVID-19 confidence in emergency use authorization vaccines: A hypothetical case of mpox.
PLoS Neglected Tropical Diseases
title Investigating post-COVID-19 confidence in emergency use authorization vaccines: A hypothetical case of mpox.
title_full Investigating post-COVID-19 confidence in emergency use authorization vaccines: A hypothetical case of mpox.
title_fullStr Investigating post-COVID-19 confidence in emergency use authorization vaccines: A hypothetical case of mpox.
title_full_unstemmed Investigating post-COVID-19 confidence in emergency use authorization vaccines: A hypothetical case of mpox.
title_short Investigating post-COVID-19 confidence in emergency use authorization vaccines: A hypothetical case of mpox.
title_sort investigating post covid 19 confidence in emergency use authorization vaccines a hypothetical case of mpox
url https://doi.org/10.1371/journal.pntd.0013037
work_keys_str_mv AT lipingwong investigatingpostcovid19confidenceinemergencyuseauthorizationvaccinesahypotheticalcaseofmpox
AT haridahalias investigatingpostcovid19confidenceinemergencyuseauthorizationvaccinesahypotheticalcaseofmpox
AT haiyenlee investigatingpostcovid19confidenceinemergencyuseauthorizationvaccinesahypotheticalcaseofmpox
AT qinjianzhao investigatingpostcovid19confidenceinemergencyuseauthorizationvaccinesahypotheticalcaseofmpox
AT zhiwenhuang investigatingpostcovid19confidenceinemergencyuseauthorizationvaccinesahypotheticalcaseofmpox
AT zhijianhu investigatingpostcovid19confidenceinemergencyuseauthorizationvaccinesahypotheticalcaseofmpox
AT yulanlin investigatingpostcovid19confidenceinemergencyuseauthorizationvaccinesahypotheticalcaseofmpox